Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Archives

Onpattro

Onpattro is approved for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). It can also improve hATTR-related polyneuropathy. hATTR amyloidosis affects around 50,000 people globally….

We are proud to be recognized with ACHC Accreditation, recognizing Infusion for Health's Commitment To Excellence, Integrity, And Uparalleled Patient Care

Infusion for Health offers exceptional infusion therapy services in comfortable, convenient, and safe locations throughout the U.S.

Company

About Us
Careers
Contact

Get Started

For Patients
For Providers
Home Infusion
Find a Location

Learn More

Treatment & Care
Newsroom

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!